Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:4:p5
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 4 (pt 5/22)
Character Range: 193761–197411

containing 0.2% or less of emetine.
CEPHALONIUM.
CEPHRADINE.
CERITINIB.
CERIVASTATIN.
CERLIPONASE ALFA.
CERTOLIZUMAB PEGOL.
CERULETIDE.
CETIRIZINE except
 (a) when included in Schedule 2; or
 (b) in divided preparations for oral use for the treatment of seasonal allergic rhinitis in adults and children 6 years of age and over when:

          (i) in a primary pack containing not more than 10 days' supply; and

          (ii) labelled with a recommended daily dose not exceeding 10 mg of cetirizine.
CETRORELIX.
CETUXIMAB.
CHENODEOXYCHOLIC ACID.
CHLORAL FORMAMIDE.
CHLORAL HYDRATE except in preparations for topical use containing 2% or less of chloral hydrate.
CHLORALOSE except when included in Schedule 6.
CHLORAMBUCIL.
CHLORAMPHENICOL except when included in Schedule 3.
# CHLORANDROSTENOLONE.
CHLORAZANIL.
CHLORCYCLIZINE.
# CHLORDIAZEPOXIDE.
CHLORMERODRIN.
CHLORMETHIAZOLE.
CHLORMEZANONE.
CHLOROFORM for use in anaesthesia.
# 4‑CHLOROMETHANDIENONE.
2‑(4‑CHLOROPHENYL)‑(1,2,4)TRIAZOLO[5,1‑A]ISOQUINOLINE.
CHLOROQUINE.
CHLOROTHIAZIDE.
CHLOROTRIANISENE.
# CHLOROXYDIENONE.
CHLORPHENAMINE except when included in Schedule 2 or 3.
CHLORPHENTERMINE.
CHLORPROMAZINE.
CHLORPROPAMIDE.
CHLORPROTHIXENE.
CHLORQUINALDOL for human topical use.
CHLORTALIDONE.
CHLORTETRACYCLINE except when included in Schedule 5.
CHLORZOXAZONE.
CHOLERA VACCINE.
CHOLIC ACID.
CHYMOPAPAIN for human therapeutic use.
CICLACILLIN.
CICLESONIDE.
CICLOPIROX except:
 (a) when included in Schedule 2 or 3; or
 (b) in preparations for the treatment of tinea pedis.
CICLOSPORIN.
CIDOFOVIR.
CILASTATIN.
CILAZAPRIL.
CILGAVIMAB.
CILOSTAZOL.
CIMETIDINE except when included in Schedule 3.
CIMICOXIB.
CINACALCET.
CINCHOCAINE except when included in Schedule 2.
CINNARIZINE.
CINOXACIN.
CIPAGLUCOSIDASE ALFA.
CIPROFLOXACIN.
CISAPRIDE.
CISATRACURIUM BESILATE.
CISPLATIN.
CITALOPRAM.
# CJC‑1295 (CAS No. 863288‑34‑0).
CLADRIBINE.
CLANOBUTIN.
CLARITHROMYCIN.
CLASCOTERONE.
CLAVULANIC ACID.
CLEMASTINE except when included in Schedule 3.
CLEMIZOLE.
CLENBUTEROL.
CLEVIDIPINE.
CLIDINIUM BROMIDE.
CLINDAMYCIN.
CLIOQUINOL and other halogenated derivatives of oxyquinoline for human topical use except when separately specified in this Schedule.
CLOBAZAM.
CLOBETASOL.
CLOBETASONE (clobetasone‑17‑butyrate) except when included in Schedule 3.
CLOCORTOLONE.
CLODRONIC ACID (includes sodium clodronate).
CLOFARABINE.
CLOFAZIMINE.
CLOFENAMIDE.
CLOFIBRATE.
# CLOMIFENE.
CLOMIPRAMINE.
CLOMOCYCLINE.
# CLONAZEPAM.
CLONIDINE.
CLOPAMIDE.
CLOPIDOGREL.
CLOPROSTENOL.
# CLORAZEPATE.
CLOREXOLONE.
CLORPRENALINE.
# CLOSTEBOL (4‑chlorotestosterone).
CLOTRIMAZOLE except:
 (a) when included in Schedule 2, 3 or 6; or
 (b) in preparations for dermal use for the treatment of tinea pedis.
CLOXACILLIN.
# CLOZAPINE.
COBALT for human therapeutic use except as dicobalt edetate in preparations for the treatment of cyanide poisoning.
COBICISTAT.
COBIMETINIB.
CODEINE when compounded with one or more other therapeutically active substances:
 (a) in divided preparations containing 30 mg or less of codeine per dosage unit; or
 (b) in undivided preparations containing 1% or less of codeine.
CO‑DERGOCRINE.
COLCHICINE.
COLCHICUM AUTUMNALE.
COLESTIPOL.
COLESTYRAMINE for human therapeutic use.
COLFOSCERIL PALMITATE for human therapeutic use.
COLISTIN.
COLLAGEN in preparations for injection or implantation:
 (a) for tissue augmentation; or
 (b) for cosmetic use.
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM.
COLURACETAM.
CONCIZUMAB.
CONVALLARIA KEISKI.
CONVALLARIA MAJALIS.
COPPER COMPOUNDS for human use except:
 (a) when separately specified in these Schedules; or
 (b) in preparations for human internal use containing 5 mg